Our Product Portfolio

All our software products are consolidated within one unified core data system that can be used in the interpretation of all areas of human-related disease where genomic information is key to unlock actionable insights and improve patient outcome. 

While we cover a wide range of disease areas, Congenica's software products are also highly customisable and designed to enable rapid analysis and interpretation of next-generation sequencing data at scale, whether on-premise or as SaaS (software as a service).

Our Product Portfolio

Somatic Oncology

Despite advances in biomarker-based drug approvals and availability, NGS-based precision oncology remains underutilised, mainly due to the often large amounts of complex datasets.  To drive the democratisation of Precision Oncology, Congenica is providing fully automated end-to-end solutions for routine oncology clinical practice and highest quality patient support.